Skip to main content

What type of drug is Motegrity?

Medically reviewed by Judith Stewart, BPharm. Last updated on March 18, 2025.

Official Answer by Drugs.com

What type of constipation is Motegrity used to treat?

Motegrity (prucalopride) is a selective serotonin type 4 (5-HT4) receptor agonist. It works by enhancing colonic peristalsis to increase bowel motility in adults with chronic idiopathic constipation (CIC).

Chronic idiopathic constipation is constipation that is long-lasting and does not have any identifiable cause. It is thought that as many as 35 million adults in the U.S. may suffer from CIC. People with CIC frequently report symptoms such as hard or lumpy stools, straining during bowel movements, and incomplete bowel movements.

Motegrity (prucalopride) is the first selective serotonin type 4 (5-HT4) receptor agonist approved for CIC. Other treatments for CIC include Linzess (linaclotide) and Trulance (plecanatide). Both of these drugs are guanylate cyclase-C agonists that work by binding to intestinal epithelial cells to stimulate the secretion of water into the intestinal lumen. Linzess and Trulance are also approved for use in the treatment of irritable bowel syndrome with constipation (IBS-C).

Read next

Which drugs cause opioid-induced constipation?

Any drug that is classified as an "opioid" can cause constipation, which can be a serious side effect if not addressed. Examples of commonly prescribed opioids that may cause this side effect include morphine, tramadol, fentanyl, methadone, hydrocodone, codeine and oxycodone.

Continue reading

How long does magnesium citrate take to work?

According to the information provided with magnesium citrate liquid products, you can generally expect it to cause a bowel movement anywhere from 30 minutes to 6 hours after you drink it.

Continue reading

Mounjaro constipation: Why it happens and how to get relief?

Mounjaro can slow down stomach motility and how fast food moves through your digestive tract, which may cause or worsen constipation. Constipation occurs commonly with the use of Mounjaro, in about 6% to 7% of people. An increase in dietary fiber and fluids, regular exercise, and slowly increasing your dose at the start of treatment may help prevent constipation. Continue reading

See also:

Related medical questions

Drug information

Related support groups